Business Description
Porton Pharma Solutions Ltd
ISIN : CNE100001S57
Share Class Description:
SZSE:300363: Class ACompare
Compare
Traded in other countries / regions
300363.China IPO Date
2014-01-29Description
Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.93 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.34 | |||||
| Debt-to-EBITDA | -12.15 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.72 | |||||
| Beneish M-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20.7 | |||||
| 3-Year EBITDA Growth Rate | 7 | |||||
| 3-Year EPS without NRI Growth Rate | -5.2 | |||||
| 3-Year Book Growth Rate | 19.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.37 | |||||
| 9-Day RSI | 52.57 | |||||
| 14-Day RSI | 49.01 | |||||
| 6-1 Month Momentum % | -43.35 | |||||
| 12-1 Month Momentum % | -45.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.46 | |||||
| Quick Ratio | 1.98 | |||||
| Cash Ratio | 1.29 | |||||
| Days Inventory | 114.9 | |||||
| Days Sales Outstanding | 107.35 | |||||
| Days Payable | 165.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 6.53 | |||||
| 3-Year Dividend Growth Rate | 119.9 | |||||
| 5-Year Yield-on-Cost % | 178.06 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 0.19 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.59 | |||||
| Operating Margin % | -3.96 | |||||
| Net Margin % | -4.45 | |||||
| FCF Margin % | -21.9 | |||||
| ROE % | -2.23 | |||||
| ROA % | -1.4 | |||||
| ROIC % | -2.11 | |||||
| ROC (Joel Greenblatt) % | -3.8 | |||||
| ROCE % | -2.08 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 22 | |||||
| PS Ratio | 3.12 | |||||
| PB Ratio | 1.63 | |||||
| Price-to-Tangible-Book | 1.81 | |||||
| Price-to-Operating-Cash-Flow | 26.29 | |||||
| EV-to-EBIT | -60.23 | |||||
| EV-to-EBITDA | -60.23 | |||||
| EV-to-Revenue | 3.25 | |||||
| EV-to-FCF | -14.84 | |||||
| Price-to-Projected-FCF | 1.46 | |||||
| Price-to-Median-PS-Value | 0.49 | |||||
| Earnings Yield (Greenblatt) % | -1.66 | |||||
| FCF Yield % | -7.03 | |||||
| Forward Rate of Return (Yacktman) % | 21.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Porton Pharma Solutions Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,967.333 | ||
| EPS (TTM) (Â¥) | -0.24 | ||
| Beta | 1.39 | ||
| Volatility % | 44.13 | ||
| 14-Day RSI | 49.01 | ||
| 14-Day ATR (Â¥) | 0.679436 | ||
| 20-Day SMA (Â¥) | 16.948 | ||
| 12-1 Month Momentum % | -45.9 | ||
| 52-Week Range (Â¥) | 14.71 - 33.17 | ||
| Shares Outstanding (Mil) | 546.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Porton Pharma Solutions Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Porton Pharma Solutions Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Porton Pharma Solutions Ltd Frequently Asked Questions
What is Porton Pharma Solutions Ltd(SZSE:300363)'s stock price today?
The current price of SZSE:300363 is ¥16.94. The 52 week high of SZSE:300363 is ¥33.17 and 52 week low is ¥14.71.
When is next earnings date of Porton Pharma Solutions Ltd(SZSE:300363)?
The next earnings date of Porton Pharma Solutions Ltd(SZSE:300363) is .
Does Porton Pharma Solutions Ltd(SZSE:300363) pay dividends? If so, how much?
The Dividend Yield %  of Porton Pharma Solutions Ltd(SZSE:300363) is 6.53% (As of Today), Highest Dividend Payout Ratio of Porton Pharma Solutions Ltd(SZSE:300363) was 2.4. The lowest was 0.05. And the median was 0.14. The  Forward Dividend Yield % of Porton Pharma Solutions Ltd(SZSE:300363) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers